Oncoloxía médica

2021

1. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol

   BMC Cardiovascular Disorders, Vol. 21, Núm. 1

2. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

   Nature Communications, Vol. 12, Núm. 1

3. Acquisition of new migratory properties by highly differentiated cd4+cd28null t lymphocytes in rheumatoid arthritis disease

   Journal of Personalized Medicine, Vol. 11, Núm. 7

4. Adherence to the Sociedad Española de Oncología Médica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study

   Advances in Therapy, Vol. 38, Núm. 1, pp. 290-303

5. Advanced multi-dimensional cellular models as emerging reality to reproduce In Vitro the human body complexity

   International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-28

6. Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study

   Translational Lung Cancer Research, Vol. 10, Núm. 10, pp. 3902-3911

7. Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol

   PLoS ONE, Vol. 15, Núm. 12 December

8. Assessment of saliva and oral candidiasis levels 12, 24 and 36 months after radiotherapy in patients with head and neck cancer

   Journal of Stomatology, Oral and Maxillofacial Surgery, Vol. 122, Núm. 6, pp. 566-572

9. BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib

   JTO Clinical and Research Reports, Vol. 2, Núm. 3

10. Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging

    International Journal of Nanomedicine, Vol. 16, pp. 5923-5935

11. Blood-based protein biomarkers in bladder urothelial tumors

    Journal of Proteomics, Vol. 247

12. Breast cancer

    Medicine (Spain), Vol. 13, Núm. 27, pp. 1506-1517

13. Breast cancer patient experiences through a journey map: A qualitative study

    PLoS ONE, Vol. 16, Núm. 9 September

14. Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial

    Journal of Thoracic Oncology, Vol. 16, Núm. 12, pp. 2091-2108

15. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

    Cancers, Vol. 13, Núm. 12

16. Case-control analysis of the impact of anemia on quality of life in patients with cancer: A Qca study analysis

    Cancers, Vol. 13, Núm. 11

17. Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial

    The Lancet Oncology, Vol. 22, Núm. 6, pp. 858-871

18. Circulating free DNA and its emerging role in autoimmune diseases

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-14

19. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 445-450

20. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

    Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940